Open access peer-reviewed Edited Volume

Cardio-Oncology - Diagnosis and Therapy

Haitao Zhu

Jiangsu University, China

Dr. Zhu is a researcher in imaging diagnosis and molecular imaging research of cardiovascular and abdominal tumors. At present, he has presided over two projects of the National Nature Fund and one project of the Jiangsu Provincial Nature Fund. His relevant research results have been published in more than 30 journals at home and abroad, including 3 papers (IF>10) and 5 papers (IF>5). Dr. Zhu has participated in the compilation of three English Monographs.


Dongqing Wang

Affiliated Hospital of Jiangsu University

Dr. Wang is an experienced doctor in medical imaging diagnosis as well as a researcher in imaging diagnosis and molecular imaging research of abdominal tumors. Dr. Wang has won the Science and Technology Award of the Chinese Association of Integrated Traditional and Western Medicine, Jiangsu Medical Science and Technology Progress Award, the Jiangsu Provincial Health Commission New Technology Introduction Award, and the Zhenjiang Science and Technology Progress Award.


Oncology Cardio-Oncology Tumor Cardiovascular Disease History CMR Echocardiography PET-CT Prevention Treatment Imaging Biomarker

Register your interest in contributing to this book

Collaborate with our community and contribute your knowledge.

About the book

With the rise and development of Cardio-Oncology, the early screening and monitoring of cardiotoxicity caused by anticancer therapy are particularly vital. Common screening methods for cardiotoxicity include biomarkers, electrocardiograms, and imaging examinations. Imaging examinations such as speckle tracking echocardiography, cardiac magnetic resonance imaging (CMR), cardiac computed tomography (CCT), and radionuclide myocardial perfusion imaging can screen out cardiac injury earlier and more sensitively, and evaluate cardiac substructure and overall function more comprehensively. CMR is a multi-parameter imaging method, and multiple imaging sequences provide information on anatomy, cardiac function, tissue characteristics, blood flow, or perfusion data, all to have a more comprehensive understanding of the changes in cardiac structure and function after anticancer therapy. CMR has a high diagnostic value for common manifestations of cardiotoxicity, including myocardial ischemia, valvular disease, cardiac dysfunction, myocardial fibrosis, and pericardiac disease. At the same time, compared with traditional echocardiography, CMR is more reproducible, accurate, and sensitive, and it has more advantages in early screening and long-term monitoring.

Publishing process

Book initiated and editor appointed

Date completed: April 13th 2022

Applications to edit the book are assessed and a suitable editor is selected, at which point the process begins.

Chapter proposals submitted and reviewed

Deadline Extended: Open for Submissions

Potential authors submit chapter proposals ready for review by the academic editor and our publishing review team.

Approved chapters written in full and submitted

Deadline for full chapters: July 10th 2022

Once approved by the academic editor and publishing review team, chapters are written and submitted according to pre-agreed parameters

Full chapters peer reviewed

Review results due: September 28th 2022

Full chapter manuscripts are screened for plagiarism and undergo a Main Editor Peer Review. Results are sent to authors within 30 days of submission, with suggestions for rounds of revisions.

Book compiled, published and promoted

Expected publication date: November 27th 2022

All chapters are copy-checked and typesetted before being published. IntechOpen regularly submits its books to major databases for evaluation and coverage, including the Clarivate Analytics Book Citation Index in the Web of ScienceTM Core Collection. Other discipline-specific databases are also targeted, such as Web of Science's BIOSIS Previews.

About the editor

Haitao Zhu

Zhu Haitao, Ph.D., doctoral supervisor. Member of the Youth Committee of Jiangsu society of radiologists, and member of the head and neck group of Jiangsu society of radiology. \'333\' the third-level talents in Jiangsu Province, Six-Peak talents in Jiangsu Province, and key young medical talent in Jiangsu Province. At present, he has presided over 2 projects of the National Nature Fund and 1 project of the Jiangsu Provincial Nature Fund. His relevant research results have been published in more than 30 journals at home and abroad, including 3 papers (IF>10) and 5 papers (IF>5). Dr.Hu has participated in the compilation of 3 English Monographs.

View profile

Book chapters authored 4

Books edited 0

Introducing your Author Service Manager

Ms. Nera Butigan

As an Author Service Manager, my responsibilities include monitoring and facilitating all publishing activities for authors and editors. From chapter submission and review to approval and revision, copyediting and design, until final publication, I work closely with authors and editors to ensure a simple and easy publishing process. I maintain constant and effective communication with authors, editors, and reviewers, which allows for a level of personal support that enables contributors to fully commit and concentrate on the chapters they are writing, editing or reviewing. I assist authors in preparing their full chapter submissions and track important deadlines to ensure they are met. I help to coordinate internal processes such as linguistic review and monitor the technical aspects of the process. As an ASM I am also involved in the acquisition of editors. Whether that be identifying an exceptional author and proposing an editorship collaboration, or contacting researchers who would like the opportunity to work with IntechOpen, I establish and help manage author and editor acquisition and contact.

Ask a question

Book will be abstracted and indexed in